Heart Failure 360

Friday, October 27, 2023, 7:15 AM - 4:35 PM, Hyatt Regency Coralville, Coralville, IA

Provide updates to current guidelines for heart failure including heart failure with preserved and reduced EF, review current diagnostic studies and therapies for pulmonary hypertension and cardiogenic shock. Discuss surgical treatments including LVAD and transplant. Demonstrate current standards of care in Amyloid and Sarcoid. Utilize strategies for remote monitoring in heart failure patients.

AMA PRA Category 1 Credits™ (6.75 hours), ACPE Credit (6.75 hours), ANCC Contact Hours (6.75 hours), Non-Physician Attendance (6.75 hours)

1. Discuss the pathophysiology and diagnosis of HFpEF
2. Review the role of cardiac imaging in heart failure
3. Review the advances in cardiac imaging modalities to improve clinical utilities and outcomes in heart failure patients
4. Select patients across the heart failure spectrum which may benefit from SGLT2 inhibitors
5. Identify where and when to initiate SGLT2 inhibitors
6. Utilize updated definitions and diagnostic evaluations to recognize patients with PAH
7. Incorporate risk stratification for selecting and escalating therapy in patients with PAH, including the use of new and emerging treatment approaches
8. Describe acute heart failure vs acute Coronary Syndrome
9. Discuss escalation of mechanical circulatory support
10. Discuss how to identify patients with progressive / worsening heart failure
11. Discuss the evaluation and selection process for advanced heart failure patients
12. Identify patients suitable for heart transplant
13. Discuss organ allocation system and coming challenges
14. Review the pathogenesis and etiology of inflammatory cardiomyopathy
15. Review the role of imaging for the diagnosis & management of patients with suspected inflammatory cardiomyopathy
16. Describe the different modes of ECMO support
17. List the indications for veno-arterial ECMO
18. Identify risk and benefits to transcatheter mitral valve repair in patients with severe mitral regurgitation
19. Review current devices to assist with monitoring of volume status in the outpatient setting and identify candidates for remote monitoring
20. Discuss characteristics of cardiac amyloidosis and clinical presentations that could result in early identification and treatment

Physician $150
Nurse/Allied Health Professional $75
UI Physician $75
UI Nurse/Allied Health Professional $40
Fellow/Resident/Student - No charge

Cancellation Policy
While registration is open until the start of the symposium, we encourage early registration to enable us to provide the best possible service to participants.  A $25 fee will be charged for cancelled registrations.  No refunds will be given for cancellations made after October 20, 2023.  

In support of improving patient care, the University of Iowa Roy J. and Lucille A. Carver College of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Physician:  The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

Pharmacist: The University of Iowa Carver College of Medicine designates this knowledge-based activity for a maximum of 6.75 ACPE contact hours. Credit will be uploaded to the NABP CPE Monitor within 60 days after the activity completion. Pharmacists must complete the online evaluation and provide their NABP ID and DOB (MMDD) to receive credit. UAN: JA0000310-0000-23-054-L01-P

Nurse: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this activity for a maximum of 6.75 ANCC contact hours.

Other Provider:  All other participants will receive a certificate of participation for this conference upon completion of the online evaluation.   It is the responsibility of each attendee to determine if the continuing education programs they attend meet the requirements of their professional licensure board.

Disclosure Policy:  University of Iowa Roy J. and Lucille A. Carver College of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships have been mitigated prior to the commencement of the activity. 

Mitigation of Relevant Financial Relationships

University of Iowa Roy J. and Lucille A. Carver College of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships have been mitigated prior to the commencement of the activity.

Friday, October 27, 2023

W9 Form Exhibit at this Event